Literature DB >> 22820657

Tissue pattern recognition error rates and tumor heterogeneity in gastric cancer.

Steven J Potts1, Sarah E Huff, Holger Lange, Vladislav Zakharov, David A Eberhard, Joseph S Krueger, David G Hicks, George David Young, Trevor Johnson, Christa L Whitney-Miller.   

Abstract

The anatomic pathology discipline is slowly moving toward a digital workflow, where pathologists will evaluate whole-slide images on a computer monitor rather than glass slides through a microscope. One of the driving factors in this workflow is computer-assisted scoring, which depends on appropriate selection of regions of interest. With advances in tissue pattern recognition techniques, a more precise region of the tissue can be evaluated, no longer bound by the pathologist's patience in manually outlining target tissue areas. Pathologists use entire tissues from which to determine a score in a region of interest when making manual immunohistochemistry assessments. Tissue pattern recognition theoretically offers this same advantage; however, error rates exist in any tissue pattern recognition program, and these error rates contribute to errors in the overall score. To provide a real-world example of tissue pattern recognition, 11 HER2-stained upper gastrointestinal malignancies with high heterogeneity were evaluated. HER2 scoring of gastric cancer was chosen due to its increasing importance in gastrointestinal disease. A method is introduced for quantifying the error rates of tissue pattern recognition. The trade-off between fully sampling tumor with a given tissue pattern recognition error rate versus randomly sampling a limited number of fields of view with higher target accuracy was modeled with a Monte-Carlo simulation. Under most scenarios, stereological methods of sampling-limited fields of view outperformed whole-slide tissue pattern recognition approaches for accurate immunohistochemistry analysis. The importance of educating pathologists in the use of statistical sampling is discussed, along with the emerging role of hybrid whole-tissue imaging and stereological approaches.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22820657     DOI: 10.1097/PAI.0b013e31825552a3

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  3 in total

1.  Invasive mouse gastric adenocarcinomas arising from Lgr5+ stem cells are dependent on crosstalk between the Hedgehog/GLI2 and mTOR pathways.

Authors:  Li-Jyun Syu; Xinyi Zhao; Yaqing Zhang; Marina Grachtchouk; Elise Demitrack; Alexandre Ermilov; Dawn M Wilbert; Xinlei Zheng; Ashley Kaatz; Joel K Greenson; Deborah L Gumucio; Juanita L Merchant; Marina Pasca di Magliano; Linda C Samuelson; Andrzej A Dlugosz
Journal:  Oncotarget       Date:  2016-03-01

2.  Prognostic implications of HER2 heterogeneity in gastric cancer.

Authors:  Shigenobu Motoshima; Koji Yonemoto; Hideki Kamei; Michi Morita; Rin Yamaguchi
Journal:  Oncotarget       Date:  2018-01-18

Review 3.  Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers.

Authors:  Hesham ElHalawani; Omar Abdel-Rahman
Journal:  Ther Clin Risk Manag       Date:  2015-07-28       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.